Abstract
ABSTRACT Introduction Inflatable penile prosthesis (IPP) reservoir placement into the High Submuscular space (HSM) has been proposed as a strategy to prevent injury to organs adjacent to the Space of Retzius (SOR). SOR reservoir proximity to critical pelvic structures (CPS) has been previously established in a cadaver study. Objective We sought to evaluate reservoir distance from CPS for SOR and HSM placements using cross-sectional imaging obtained following IPP insertion. Methods We retrospectively reviewed our institutional database and identified men who underwent IPP insertion between 2007 and 2020. Men who underwent subsequent cross-sectional abdominopelvic imaging following IPP insertion until October 2020 were included in this study. Two radiologists blinded to IPP surgical technique evaluated reservoir position to determine (a) mass effect on the bladder and iliac vessels and (b) the shortest distance between each of these structures and the reservoir. Men were grouped based on reservoir placement technique (SOR vs. HSM) as documented in the operative notes. Variables were analyzed using chi-squared, fisher's exact, and student's T-tests as indicated. Results Among 1010 IPP cases performed during the study interval, 139 (13.7%) met our inclusion criteria with imaging obtained an average of 827 (± 785) days after IPP insertion. Oncologic follow-up (46%) was the most common indication for imaging. Compared with SOR reservoirs (n = 32), HSM reservoirs (n =107) were significantly less likely to induce a mass effect on the bladder (72 vs. 9%) or iliac vessels (34 vs. 4%) and were located roughly 5x further from the bladder (10 ± 22 vs. 49 ± 36 mm) and iliac vessels (5 ± 9 vs. 23 ± 26 mm, Table 1). Conclusions This study radiographically confirms that IPP reservoirs are located significantly further away from CPS following HSM placement compared to SOR placement. These findings suggest a potential patient safety benefit via avoidance of bladder and iliac vessel-related IPP reservoir complications. Disclosure Any of the authors act as a consultant, employee or shareholder of an industry for: Boston Scientific and Coloplast
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.